20552 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters Agar; Agarose; Agaropectin
Vascular Constructs
#2ULTRASOUND RESPONSIVE MICRO-COMPOSITE MARKERS
#3Soft Tissue Filler and Methods
#4Use of agar-derived oligosaccharides for inhibiting growth of
#5Superabsorbent materials and methods of making the same
#6Methods for reducing cholesterol with superabsorbent materials
#7Treatment for obesity with superabsorbent materials
#8Vascular constructs
#9Superabsorbent materials and methods of making the same
#10Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
#11Use of agarobiose or agarooligosaccharide having anticariogenic activity
#12Preparation method for various novel fucosyl oligosaccharides and use thereof
#13USE OF AGAROBIOSE OR AGAROOLIGOSACCHARIDE HAVING ANTICARIOGENIC ACTIVITY
#14Composition for promotng bone formation with fermented oysters and seaweed
#15Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock
#16Composition for preventing, alleviating, or treating arthritis or osteoporosis, containing neoagarooligosaccharide
#17Ultrasound responsive micro-composite markers
#18Treatment of Arthritis and Other Musculoskeletal Disorders With Crosslinked Hyaluronic Acid
#19Vascular constructs
#20Composition Comprising Neoagarooligosaccharide As Active Ingredient, For Prevention or Treatment of Sepsis or Septic Shock
#21Methods for purifying polysaccharides and pharmaceutical compositions and medical devices containing the same
#22Self-gelling alginate systems and uses thereof
#23Capture of pathogenic and non-pathogenic biopolymers and bioparticles
#24Absorbent dressings with painkilling activity
#25Treatment of Arthritis and Other Musculoskeletal Disorders With Crosslinked Hyaluronic Acid
#26Methods and compositions for in vitro and in vivo chondrogenesis
#27Use of dietary fibres against muscle wasting
#28Treatment of Fibrosis related disorders
#29Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
#30Compositions and methods for suppressing fibrocytes
#31Materials and methods for wound treament
#32ACTIVITY ENHANCER FOR DETOXIFYING ENZYME
#33Self-gelling alginate systems and uses thereof
#34Wound healing compositions, systems, and methods
#35Treatment methods for fibrosis related disorders
#36Pharmaceutical composition for meniere's disease
#37NOVEL HYDROGEL COMPOSITIONS AND METHODS OF USING
#38Gel type enteral nutrient
#39Use of dietary fibres against muscle wasting
#40Materials and methods for wound treatment
#41Compositions for regulating metabolic disorders and methods of use thereof
#42Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
#43Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
#44Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
#45Compositions and methods for treating diabetes
#46Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
#47Self-gelling alginate systems and uses thereof
#48Vulnerable plaque treatment
#49Compositions and methods for treating mammals with modified alginates and modified pectins
#50Wound healing dressing for enhancing fibrocyte formation
#51Methods of suppressing fibrosis and fibrocyte formation
#52Local regional chemotherapy and radiotherapy using in situ hydrogel
#53Local regional chemotherapy and radiotherapy using in situ hydrogel
#54Prevention of loss of tight cell junctions using carbohydrate-containing compositions
#55Remedies
#56Methods of treating diseases responsive to Induction of Apoptosis
#57Soft tissue filler and methods